Brokerages Set KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Price Target at $24.83
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) has been assigned an average recommendation of “Buy” from the eight analysts that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month […]
KalVista Pharmaceuticals, Inc. (NASDAQ:KALV – Get Free Report) has been assigned an average recommendation of “Buy” from the eight analysts that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month […]
